Akari Therapeutics names Kameel Farag as interim CFO
Go back to Akari Therapeutics names Kameel Farag as interim CFO| (NASDAQ: AKTX) | Delayed: 7.79 -0.11 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.90 | 52 Week High | $19.75 | |||
| Open | $8.10 | 52 Week Low | $7.63 | |||
| Day High | $8.10 | P/E | N/A | |||
| Day Low | $7.69 | EPS | $0.00 | |||
| Volume | 16,537 | |||||

